SCHEMBL274876

SCHEMBL274876

[C]1C[CH]CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1723224 0.90
SCHEMBL105736 0.79
SCHEMBL104907 0.79
SCHEMBL2795828 0.71
SCHEMBL7697373 0.71
SCHEMBL132687 0.62
SCHEMBL1110010 0.60
SCHEMBL958835 0.59
SCHEMBL93125 0.55
SCHEMBL5310 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8999956-B2 N-[(het)arylalkyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-04-07 US claimed
EP-2576517-B1 N-[(HET)ARYLALKYL)]PYRAZOLE (THIO)CARBOXAMIDES AND THEIR HETEROSUBSTITUTED ANALOGUES BAYER IP GMBH (DE) 2014-12-17 EP claimed
EP-2576517-A1 N-[(HET)ARYLALKYL)]PYRAZOLE (THIO)CARBOXAMIDES AND THEIR HETEROSUBSTITUTED ANALOGUES Bayer Cropscience AG (DE) 2013-04-10 EP claimed
US-20130079302-A1 N-[(HET)ARYLALKYL)] PYRAZOLE(THIO)CARBOXAMIDES AND THEIR HETEROSUBSTITUTED ANALOGUES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-03-28 US claimed
WO-2011151370-A1 N-[(HET)ARYLALKYL)] PYRAZOLE (THIO)CARBOXAMIDES AND THEIR HETEROSUBSTITUTED ANALOGUES BAYER CROPSCIENCE AG (DE) 2011-12-08 WO claimed
EP-2344449-A1 ARYL-PHENYL-SULFONAMIDO-CYCLOALKYL COMPOUNDS AND THEIR USE Pimco 2664 Limited (GB) 2011-07-20 EP claimed
WO-2010032009-A1 ARYL-PHENYL-SULFONAMIDO-CYCLOALKYL COMPOUNDS AND THEIR USE PIMCO 2664 LIMITED (GB) 2010-03-25 WO claimed
EP-1423467-A1 FLUXING COMPOSITIONS 3M Innovative Properties Company (US) 2004-06-02 EP claimed
US-20030111519-A1 Fluxing compositions 3M INNOVATIVE PROPERTIES COMPANY 2003-06-19 US claimed
WO-2003020816-A1 FLUXING COMPOSITIONS 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-03-13 WO claimed
CN-114181205-B Pyrazolopyridine compound or salt thereof, and preparation method and application thereof 励缔(杭州)医药科技有限公司 2024-06-11 CN disclosed
CN-114478519-B Pyrazolopyridine compound or salt thereof, and preparation method and application thereof 励缔(杭州)医药科技有限公司 2024-06-11 CN disclosed
CN-117916215-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2024-04-19 CN disclosed
CN-116472034-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2023-07-21 CN disclosed
CN-116063305-A Macrocyclic compounds with BTK and/or RET activity and their use in medicine 赛诺哈勃药业(成都)有限公司 2023-05-05 CN disclosed
WO-2003099858-A1 CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS THERAVANCE, INC. (US) 2003-12-04 WO disclosed
US-20030130173-A1 Cross-linked glycopeptide-cephalosporin antibiotics THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC 2003-07-10 US disclosed
US-20030111519-A1 Fluxing compositions 3M INNOVATIVE PROPERTIES COMPANY 2003-06-19 US disclosed
WO-2003031449-A2 CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS THERAVANCE, INC. (US) 2003-04-17 WO disclosed
WO-2003020816-A1 FLUXING COMPOSITIONS 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-03-13 WO disclosed